|
Re: Additional Exempt Distribution
|
|
Zenith Epigenetics
|
Dec 04, 2023 11:45AM
|
|
Re: Additional Exempt Distribution- 2023-03-31
|
4
|
Zenith Epigenetics
|
Apr 12, 2023 10:54AM
|
|
Re: Additional Exempt Distributions
|
2
|
Zenith Epigenetics
|
Oct 09, 2023 03:36PM
|
|
Re: Additional Exempt Distributions
|
1
|
Zenith Epigenetics
|
Oct 14, 2023 05:01AM
|
|
Re: Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 22, 2023 07:01AM
|
|
Re: Additional Reports of Exempt Distribution
|
1
|
Zenith Epigenetics
|
Jul 22, 2023 11:48AM
|
|
Re: Additional Reports of Exempt Distribution - 2023-04-28
|
3
|
Resverlogix Corp.
|
May 09, 2023 09:43AM
|
|
Re: Additional Reports Of Exempt Distribution.
|
1
|
Zenith Epigenetics
|
Jun 05, 2024 08:46PM
|
|
Re: Additional Reports Of Exempt Distribution.
|
|
Zenith Epigenetics
|
Jun 06, 2024 08:28AM
|
|
Re: Additional Reports Of Exempt Distribution.
|
1
|
Zenith Epigenetics
|
Jul 03, 2024 06:17AM
|
|
Re: Additional Reports Of Exempt Distribution.
|
2
|
Zenith Epigenetics
|
Jun 20, 2024 12:47PM
|
|
Re: Additional Thoughts
|
1
|
Resverlogix Corp.
|
Oct 03, 2019 07:47AM
|
|
Re: Additional Thoughts
|
4
|
Resverlogix Corp.
|
Oct 03, 2019 08:44AM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
3
|
Resverlogix Corp.
|
May 13, 2020 03:49PM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
4
|
Resverlogix Corp.
|
May 14, 2020 10:26AM
|
|
Re: Adjudication
|
1
|
Resverlogix Corp.
|
Jan 30, 2019 06:51AM
|
|
Re: Aducanumab and the amyloid beta hypothesis is not dead yet!
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 23, 2019 12:32PM
|
|
Re: AGM
|
2
|
Resverlogix Corp.
|
Jun 20, 2023 09:11AM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Jun 20, 2023 10:03AM
|
|
Re: AGM
|
1
|
Resverlogix Corp.
|
Jun 05, 2023 12:02PM
|
